Molecular mechanisms of L-DOPA-induced dyskinesia

@article{Jenner2008MolecularMO,
  title={Molecular mechanisms of L-DOPA-induced dyskinesia},
  author={P Feroz Jenner},
  journal={Nature Reviews Neuroscience},
  year={2008},
  volume={9},
  pages={665-677}
}
L-DOPA (L-3,4-dihydroxyphenylalanine) remains the most effective drug for the treatment of Parkinson's disease. However, chronic use causes dyskinesia, a complex motor phenomenon that consists of two components: the execution of involuntary movements in response to drug administration, and the 'priming' phenomenon that underlies these movements' establishment and persistence. A reinterpretation of recent data suggests that priming for dyskinesia results from nigral denervation and the loss of… CONTINUE READING
Highly Influential
This paper has highly influenced a number of papers. REVIEW HIGHLY INFLUENTIAL CITATIONS